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Introduction: Currently, advanced technology leading to ecological 
disasters, incorrect nutrition with many chemical additives, hard 
intellectual work, etc., affect the functionality of the immune system, 
predisposing the body to various attacks of microorganisms. All these 
directs researchers to study and discover new immunomodulatory drugs, 
including imupurin, a biologically active substance extracted from the 
larvae of butterflies of the order Lepidoptera, Lemantria family.  
 Previous studies on the pharmacological properties of imupurin have 
shown that the preparation has an immunotropic effect; increases 
nonspecific resistance in vivo studies.  
Purpose: Study of the immunomodulatory effect of imupurin on leukocyte 
formula in dexamethasone-induced secondary immunodeficiency. 
 
  Material and methods: The study included 31 rats, weighing 180.80 ± 
5.99, of both sexes. The animals were randomly divided into 3 groups: G0-  
were given intraperitoneal saline solution, 0,9%-0,2 ml, G1-was 
administered dexamethasone  sol. 2.5 mg / kg / body; G2- was given 
imupurin, internally 500 mg / kg in combination with dexamethasone. For  
                                the prophylaxis of bacterial infections, 500  mg / l   
                               doxycycline was added to the water of the animals. To  
                               determine the immunomodulatory effect, was collected  
                               blood from the inferior cava vena after general  
                               anesthesia with ketamine. 
Results: Experimental research has shown that dexamethasone reduced 
the percentage of lymphocytes by 50% compared to the control-negative 
group (34.4 ± 6.73 versus 61.23 ± 3.35; P <0.05) and increased neutrophils 
(55, 78 ± 7.57 versus 28.36 ± 2.91; P <0.05). G2, wich received imupurine 
plus  dexamethasone, resulted in a more significant reduction in 
 
lymphocyte percentage compare with Go group (24.54 ± 4.6 versus 61.23 ± 3.35; 
P <0.05) and an increase in neutrophil counts (66.34 ± 4, 42 versus 28.36 ± 2.91; 










During 5 weeks, animals were supervised; Go did not show any changes in 
behavior, the skin, mucous membranes and the hairy part remained unchanged. 
An insignificant change was weight gain of approximately 16.18 grams per batch. 
G1 showed weight loss of 38.4 grams per batch. A hair loss (alopecia) was 
observed on the entire body surface in all rats and towards the end of the study 
period the rats became apathetic, drowsy. In addition, diarrhea occurred in 2 
rats, others 3- left ear infection, with the formation on the earlobe of some 
concretions(image nr.1, nr.2).  
The study group, were also monitored to  
determine body weight, which by  
the end of the study had decreased 
 by up to 54 grams per group.  
The following table (Nr.2) shows the changes in body mass during the research 
Conclusions:Dexamethasone produced a secondary immunodeficiency, and the preparation of entomological 
origin did not prevent glucocorticoid-induced lucocyte formula disorders. 
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Date of body weight determination Go G1 G2 
28.05.19 168,18±9,26 181,5±11,84 194,0±7,95 
13.06.19 176,09±7,49 162,0±9,05 166,3±5,7 
3.07.19 184,27±7,35 143,1±8,19 140,1±8,44 
                                                                                              --      
                                                                                                                                                                                                                                                            
                Image nr.1                                    Image nr.2                                       
